H R Cardenes

Summary

Affiliation: Indiana University
Country: USA

Publications

  1. ncbi request reprint Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results
    H R Cardenes
    Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, USA
    Clin Transl Oncol 11:276-83. 2009
  2. doi request reprint Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma
    Higinia R Cardenes
    Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis 46202, USA
    Clin Transl Oncol 12:218-25. 2010
  3. doi request reprint A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study
    Higinia R Cardenes
    Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA
    Am J Clin Oncol 34:460-5. 2011
  4. doi request reprint Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy
    C C Olsen
    Department of Radiation Oncology, University of Colorado, Denver, Aurora, CO 80045 000508, USA
    Int J Radiat Oncol Biol Phys 73:1414-24. 2009

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results
    H R Cardenes
    Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, USA
    Clin Transl Oncol 11:276-83. 2009
    ..This manuscript reviews the role of stereotactic body radiotherapy in HCC...
  2. doi request reprint Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma
    Higinia R Cardenes
    Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis 46202, USA
    Clin Transl Oncol 12:218-25. 2010
    ..Hepatocellular carcinoma (HCC) is increasing in incidence and the majority of patients are not candidates for radical therapies. Therefore, interest in minimally invasive therapies in growing...
  3. doi request reprint A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study
    Higinia R Cardenes
    Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA
    Am J Clin Oncol 34:460-5. 2011
    ..A Phase II study was conducted at Indiana University to evaluate the safety and efficacy of combined weekly Gemcitabine (GEM) with external beam radiotherapy (RT) in unresectable, locally advanced pancreatic cancer (LAPC)...
  4. doi request reprint Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy
    C C Olsen
    Department of Radiation Oncology, University of Colorado, Denver, Aurora, CO 80045 000508, USA
    Int J Radiat Oncol Biol Phys 73:1414-24. 2009
    ..To describe the histologic and volumetric changes in normal liver tissue after stereotactic body radiotherapy (SBRT) for liver metastases...